Healthcare firm Longhorn Vaccines has approached U.S. Patent and Trademark Office’s (USPTO) director, conveying their dissent over Patent Trial and Appeal Board’s (PTAB) decision. They argued that the Board had wrongly abolished five patents belonging to the company. The alleged gaffe, however, was outlined by the company to be the mistake of their erstwhile outside counsel and not Longhorn itself.
- The health sector organization Longhorn Vaccines addressed the head of the U.S Patent and Trademark Office (USPTO) expressing its dissent regarding the PTAB’s judgement. The company claimed PTAB erred in invalidating their five patents.
- Longhorn pinpointed the origin of the error not as a company fault, but a blunder committed by their former external legal counsel.
To learn about the comprehensive details of this development, you can refer to the original report regarding the episode.